Alaunos Therapeutics, Inc.
TCRT
$1.46
-$0.02-1.35%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 86.70% | 87.14% | 83.26% | 14.37% | 4.24% |
| Total Depreciation and Amortization | -100.00% | -99.86% | -99.71% | -65.27% | -1.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -96.23% | -93.26% | -83.19% | 413.89% | 131.37% |
| Change in Net Operating Assets | 137.95% | 49.85% | 73.16% | -241.42% | -180.76% |
| Cash from Operations | 87.75% | 75.99% | 79.57% | -3.58% | -3.73% |
| Capital Expenditure | -- | -- | -- | 100.00% | 92.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 6,434.78% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 1,716.13% | 107.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.75% | 91.21% | 87.68% | -570.18% | 22.90% |
